NVO
Novo Nordisk A/s
Danish pharmaceutical company focused on diabetes and obesity care, and rare blood and endocrine disorders
ADRUnderlying: NVOCUSIP: 670100205HealthcareDK4 holders
American Depositary Receipt representing Novo Nordisk A/S common stock
Recent Activity
2025Q4
1 buy1 sell
-138.9K shares
-138.9K shares
+501.1K shares(+21.2%)
+501.1K shares(+21.2%)
Loading more activity...